Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the clinical consequences of polypharmacy in older adults: a narrative review
Jonas W. Wastesson, Lucas Morin, Edwin C.K. Tan, et al.
Expert Opinion on Drug Safety (2018) Vol. 17, Iss. 12, pp. 1185-1196
Open Access | Times Cited: 452

Showing 1-25 of 452 citing articles:

An overview of prevalence, determinants and health outcomes of polypharmacy
Mina Khezrian, Christopher J. McNeil, Alison D. Murray, et al.
Therapeutic Advances in Drug Safety (2020) Vol. 11
Open Access | Times Cited: 314
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Farhad Pazan, Martin Wehling
European Geriatric Medicine (2021) Vol. 12, Iss. 3, pp. 443-452
Open Access | Times Cited: 270
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age
Felipe A. Martínez, Matteo Serenelli, José Carlos Nicolau, et al.
Circulation (2019) Vol. 141, Iss. 2, pp. 100-111
Open Access | Times Cited: 179
Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study
Tae Ik Chang, Haeyong Park, Dong Wook Kim, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 169
Barriers and facilitators to deprescribing in primary care: a systematic review
Alison Jayne Doherty, Paul Boland, Janet Reed, et al.
BJGP Open (2020) Vol. 4, Iss. 3, pp. bjgpopen20X101096-bjgpopen20X101096
Open Access | Times Cited: 156
Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review
Kathryn Nicholson, Winnie Liu, Daire W. D. Fitzpatrick, et al.
The Lancet Healthy Longevity (2024) Vol. 5, Iss. 4, pp. e287-e296
Open Access | Times Cited: 30
Surveillance of Antibiotic Use and Adherence to the WHO/INRUD Core Prescribing Indicators at a Primary Healthcare Hospital in Southern Zambia: Opportunities for Antimicrobial Stewardship Programs
Steward Mudenda, Ronald Simbaya, Given Moonga, et al.
Pharmacology & Pharmacy (2025) Vol. 16, Iss. 01, pp. 1-19
Open Access | Times Cited: 1
Enhancing the Clinical Relevance of Al Research for Medication Decision-Making
Qi Wang, Mingxian Chen
Journal of Medical Internet Research (2025) Vol. 27, pp. e70657-e70657
Open Access | Times Cited: 1
Diabetes in Peripheral Artery Disease: Prevalence, Complications, and Polypharmacy
Manon Baty, Ritesh Chimoriya, Sophie James, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1383-1383
Open Access | Times Cited: 1
Withdrawal of antihypertensive drugs in older people
Emily Reeve, Vanessa Jordan, Wade Thompson, et al.
Cochrane library (2020) Vol. 2020, Iss. 6
Open Access | Times Cited: 90
Polypharmacy definition and prevalence in heart failure: a systematic review
Janine Beezer, Manal Al Hatrushi, Andy Husband, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 2, pp. 465-492
Open Access | Times Cited: 87
Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy
Federico Rea, Annalisa Biffi, Raffaella Ronco, et al.
JAMA Network Open (2021) Vol. 4, Iss. 6, pp. e2113186-e2113186
Open Access | Times Cited: 66
Adverse Drug Reactions of Acetylcholinesterase Inhibitors in Older People Living with Dementia: A Comprehensive Literature Review
Sirasa Ruangritchankul, Prawat Chantharit, Sahaphume Srisuma, et al.
Therapeutics and Clinical Risk Management (2021) Vol. Volume 17, pp. 927-949
Open Access | Times Cited: 65
The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiß, Martin Wehling, et al.
Drugs & Aging (2022) Vol. 39, Iss. 3, pp. 245-247
Open Access | Times Cited: 46
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
Juan Tamargo, Keld Per Kjeldsen, Eva Delpón, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 8, Iss. 4, pp. 406-419
Open Access | Times Cited: 44
Delayed presentation of HIV among older individuals: a growing problem
Amy C. Justice, Matthew Bidwell Goetz, Cameron Stewart, et al.
The Lancet HIV (2022) Vol. 9, Iss. 4, pp. e269-e280
Open Access | Times Cited: 44
Prevalence and trends of polypharmacy in U.S. adults, 1999–2018
Xiaowen Wang, Keyang Liu, Kokoro Shirai, et al.
Global Health Research and Policy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 38
Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study
Jamila Abou, Stijn Crutzen, Vashti N. M. F. Tromp, et al.
Drugs & Aging (2022) Vol. 39, Iss. 3, pp. 209-221
Open Access | Times Cited: 37
Gut Enterobacteriaceae and uraemic toxins - Perpetrators for ageing
Seenivasan Boopathi, Rashmi Kumar, P. Snega Priya, et al.
Experimental Gerontology (2023) Vol. 173, pp. 112088-112088
Open Access | Times Cited: 26
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
Jia You, Canqing Yu, Jujiao Kang, et al.
Stroke and Vascular Neurology (2023) Vol. 8, Iss. 6, pp. 475-485
Open Access | Times Cited: 25
Older adults in psychedelic-assisted therapy trials: A systematic review
Lisa Bouchet, Zachary Sager, Antoine Yrondi, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 1, pp. 33-48
Closed Access | Times Cited: 9
Global and regional prevalence of polypharmacy and related factors, 1997–2022: An umbrella review
Sun Young Kim, Hyeri Lee, Jaeyu Park, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 124, pp. 105465-105465
Closed Access | Times Cited: 8
Antipsychotic Polypharmacy: A Dirty Little Secret or a Fashion?
Shih‐Ku Lin
The International Journal of Neuropsychopharmacology (2019) Vol. 23, Iss. 2, pp. 125-131
Open Access | Times Cited: 67
Mortality of Older Patients Admitted to an ICU: A Systematic Review*
Hélène Vallet, G. Schwarz, Hans Flaatten, et al.
Critical Care Medicine (2020) Vol. 49, Iss. 2, pp. 324-334
Open Access | Times Cited: 63
High Prevalence of Multimorbidity and Polypharmacy in Elderly Patients With Chronic Pain Receiving Home Care are Associated With Multiple Medication-Related Problems
Juliana Schneider, Engi Algharably, Andrea Budnick, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top